Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 14, 2019, the Board of Directors (the "Board") of Biolase, Inc. (the
"Company") elected Michael DiTolla to the Board.
Michael DiTolla, 55, is currently Vice President of Clinical Affairs for AEGIS
Communications. From 2015 to 2017, Dr. DiTolla served as Director of Clinical
Affairs for Dentsply Sirona, and from 2001 to 2016 he served as Director of
Clinical Education and Research at Glidewell Laboratories. Prior to his dental
executive experience, Dr. DiTolla practiced restorative and esthetic dentistry
from 1988 to 2001.
Dr. DiTolla was awarded Fellowship in the Academy of General Dentistry in 1995.
He received his Bachelor of Science in Biology from Occidental College and a
Doctor of Dental Surgery from University of the Pacific School of Dentistry.
There are no understandings or arrangements between Dr. DiTolla or any other
person and the Company or any of its subsidiaries pursuant to which Dr. DiTolla
was selected to serve as a director of the Company. There are no family
relationships between Dr. DiTolla and any director, executive officer or person
nominated or chosen by the Company to become a director or executive officer,
and there are no transactions between Dr. DiTolla or any of his immediate family
members and the Company or any of its subsidiaries.
Pursuant to the terms of the Company's 2018 Long-Term Incentive Plan, upon his
election to the Board, Dr. DiTolla received an automatic award of 98,738
stock-settled restricted stock units, which fully vest on May 15, 2020. Upon
vesting, each unit shall be settled with one share of Company's Common Stock.
Item 7.01 Regulation FD Disclosure.
On November 15, 2019, the Company issued a press release announcing the election
of Dr. DiTolla to the Board, a copy of which is attached as Exhibit 99.1 to this
Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release of Biolase, Inc., dated November 15, 2019.
2
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses